| 2015 | A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2016 | Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis | DISEASES OF THE COLON & RECTUM |
| 2019 | Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox | JOURNAL OF SURGICAL ONCOLOGY |
| 2009 | Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases | AMERICAN JOURNAL OF SURGERY |
| 2020 | Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CA | ONCOLOGY |
| 2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | Oncology |
| 2019 | Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients
| Medicine |
| 2012 | Impact of fat obesity on laparoscopic total mesorectal excision: more reliable indicator than body mass index | INTERNATIONAL JOURNAL OF COLORECTAL DISEASE |
| 2018 | Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2016 | MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection
| PLOS ONE |
| 2020 | Nomogram for prediction of pathologic complete remission using biomarker expression and endoscopic finding after preoperative chemoradiotherapy in rectal cancer
| CHINESE JOURNAL OF CANCER RESEARCH |
| 2015 | Novel methods for clinical risk stratification in patients with colorectal liver metastases
| CANCER RESEARCH AND TREATMENT |
| 2023 | Postchemoradiation magnetic resonance imaging circumferential resection margin predicts treatment failure after multidisciplinary directed sphincter preservation in low rectal cancer | JOURNAL OF SURGICAL ONCOLOGY |
| 2016 | Profiling of rectal cancers MRI in pathological complete remission states after neoadjuvant concurrent chemoradiation therapy | CLINICAL RADIOLOGY |
| 2016 | Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma
| BMC CANCER |
| 2016 | Prognostic implications of PIK3CA amplification in curatively resected liposarcoma
| ONCOTARGET |
| 2018 | Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.
| BMC CANCER |
| 2016 | Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.
| JOURNAL OF CANCER |
| 2017 | Rectal Mucinous Adenocarcinoma: MR Imaging Assessment of Response to Concurrent Chemotherapy and Radiation Therapy-A Hypothesis-generating Study | RADIOLOGY |
| 2017 | Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancer
| JOURNAL OF RADIATION RESEARCH |
| 2021 | Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
| FRONTIERS IN ONCOLOGY |
| 2014 | The magnetic resonance imaging-based approach for identification of high-risk patients with upper rectal cancer | ANNALS OF SURGERY |
| 2010 | Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2020 | Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
| TRIALS |
| 2015 | Use of Preoperative MRI to Select Candidates for Local Excision of MRI-Staged T1 and T2 Rectal Cancer: Can MRI Select Patients With N0 Tumors? | DISEASES OF THE COLON & RECTUM |
